INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against ChemoCentryx, Inc. and Encourages Investors with Losses to Contact the Firm

By Business Wire8 days ago

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ChemoCentryx, Inc. (ChemoCentryx or the Company) (NASDAQ: CCXI) for violations of the securities laws.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. The FDA released a Briefing Document on May 4, 2021, concerning ChemoCentryx's drug candidate avacopan. The FDA document notes that the agency's review team has identified several areas of concern, raising uncertainties about the interpretability of the data found in the Company's application, and also holds concerns about the clinical meaningfulness of these results. Based on this news, shares of ChemoCentryx plunged by more than 45% on the same day.


If you are a shareholder who suffered a loss, click here to participate.

Continue read on